Literature DB >> 34001498

The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".

Gregg Gonsalves1, Gavin Yamey2.   

Abstract

Entities:  

Year:  2021        PMID： 34001498     DOI： 10.1136/bmj.n1249

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review.

Authors:  Kunmeng Liu; Xiaoming Zhang; Yuanjia Hu; Weijie Chen; Xiangjun Kong; Peifen Yao; Jinyu Cong; Huali Zuo; Jian Wang; Xiang Li; Benzheng Wei
Journal:  Front Med (Lausanne)       Date:  2022-07-01

2.  A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property.

Authors:  Özgür Kasapçopur
Journal:  Turk Arch Pediatr       Date:  2021-07-01

3.  Global Vaccine Equity to End the COVID-19 Pandemic: A Canadian Perspective and Call to Action.

Authors:  Michael Clarke; Shehzad Ali; Michael Silverman; Saverio Stranges
Journal:  Int J Public Health       Date:  2022-01-27       Impact factor: 3.380

Review 4.  Competing Responses to Global Inequalities in Access to COVID Vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.

Authors:  Matthew Sparke; Orly Levy
Journal:  Clin Infect Dis       Date:  2022-08-15       Impact factor: 20.999

5.  Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching.

Authors:  Vivencio O Ballano
Journal:  Linacre Q       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.